Navigation Links
UTHealth stem cell scientists explore treatments for blood disorders and lung diseases
Date:4/12/2010

can be coaxed to develop into hundreds of different cell types. A new strategy to generate transplantable HSCs will be tested under laboratory conditions.

Human embryonic stem cells are not the only cells capable of developing into a wide variety of cell types, which scientists describe as pluripotency. Skin cells can be converted into "induced pluripotent stem cells" or iPS cells, which are believed to have many of the same capabilities as human embryonic stem cells.

If successful, Simmons' strategy could possibly be used to coax iPS cells into becoming HSCs, too. Researchers at UTHealth use human embryonic stem cells approved by the National Institutes of Health.

"This proposal seeks to develop markedly improved strategies to derive HSC from pluripotent stem cells and to further the development of novel cellular therapies for treating blood diseases," Simmons said.

The second research project is led by one of Simmons' colleagues at the UTHealth Centre for Stem Cell Research, associate professor Brian Davis, Ph.D., who along with UTHealth molecular medicine professor Rick Wetsel, Ph.D., is looking into a new way to treat two pediatric lung diseases linked to single gene defects Surfactant Protein B Deficiency and Cystic Fibrosis.

Surfactant is a protein that helps keep lungs inflated and a shortage can lead to severe respiratory disease. Surfactant deficient infants are extremely ill and without neonatal intensive care intervention, including ventilation, they will die shortly after birth. Even with intensive care intervention, these infants may only survive for a short time (weeks to months) if they do not receive a lung transplant.

Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide), according to the Cystic Fibrosis Foundation. A defective gene and its protein product cause the body to produce
'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Community involvement important in fight against childhood obesity, according to UTHealth researchers
2. Scientists uncover new species of human ancestor
3. IUs Carlson among team of scientists announcing new species of prehistoric man
4. Powerful new method allows scientists to probe gene activation
5. ARS scientists develop self-pollinating almond trees
6. International team of scientists describe first Cretaceous African amber deposit
7. Leading conservation scientists awarded prestigious 2010 Tyler Environmental Prize
8. Tiny gold probes give scientists a sense of how disease develops
9. Scientists link climate change and Atlantic croaker fishery
10. Queens scientists boost endangered freshwater mussels population
11. US women and minority scientists discouraged from pursuing STEM careers, national survey shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UTHealth stem cell scientists explore treatments for blood disorders and lung diseases
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced ... - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of AuthenTec ... with the iPhone 5S. It is currently the only ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2
... biofuel? Now that a University of Illinois metabolic engineer has ... of fermenting galactose, the answer is an unequivocal yes. ... miscanthus, and switchgrass. ln small island or peninsular nations, though, ... a U of I assistant professor of microbial genomics and ...
... found a key to keeping stem cells in their neutral ... published in the journal PLoS One , the researchers ... soft gel rather than on a hard plate or dish ... the ability to become any type of tissue. The soft ...
... 15, 2010 For Immediate Release The Scripps ... (UCSD) School of Medicine have been awarded approximately $7.5 ... could eventually become drug candidates for the treatment of ... funds awarded, $5 million will go to Scripps Research, ...
Cached Biology News:Seaweed as biofuel? Metabolic engineering makes it a viable option 2Soft substrate promotes pluripotent stem cell culture 2Soft substrate promotes pluripotent stem cell culture 3Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 2Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 3
(Date:1/22/2015)... 22, 2015 Shimadzu Scientific Instruments ... multipurpose UV-visible spectrophotometer. Offering wavelength scanning from 190 ... ideal for applications in a variety of industries, ... The user-friendly UV-1280 enables intuitive operation, while the ...
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... May 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) announced ... present at the Rodman & Renshaw Annual Global Investment Conference taking place in ... , , ... Summer Time ( 5:15 a.m. Eastern Daylight Time ) on Tuesday, May ...
... May 12 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. ... drug development company specialized in oncology and endocrine ... Drug Administration (FDA) has approved the Company,s Investigational ... conjugate compound, AEZS-108, in luteinizing hormone releasing hormone ...
... 2010 , , , ... New Outcomes Trial to Expand Evidence for Dronedarone in a Different AF,Population , ... Sanofi-aventis (EURONEXT: SAN and NYSE: ... to assess the potential clinical benefit of Multaq(R) (dronedarone),in over 10, 000 patients with ...
Cached Biology Technology:Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer 2Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer 3Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 2Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 3Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 4Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 5Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 6Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 7Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 8Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 9Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 10
JTV1 gene...
APO-BrdU™ TUNEL Assay Kit *with Alexa Fluor® 488 anti-BrdU* *60 assays*...
The FlowTACS Apoptosis Detection Kit is designed specifically for in situdetection of apoptotic...
Recombinant Rat PTX2/SAP...
Biology Products: